Avoro Capital Advisors LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1633313
NEW YORK, NY
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$984,408,154
+$32,644,946 QoQ
Shares Held
1,833,333
+0.8% QoQ
Ownership
7.94%
of shares outstanding
% of Portfolio
8.84%
of 13F equity value
Holder Rank
#4
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avoro Capital Advisors LLC holds $9,631,167,263 across 25 Biotechnology names. MDGL ranks #3 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
5,111,111 | $1,363,235,525 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
2,888,888 | $1,073,713,002 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
This page
|
1,833,333 | $984,408,154 | |
| 4 | ARGX |
Argenx SE
|
1,000,000 | $927,770,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,355,555 | $925,591,288 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
7,474,747 | $857,129,238 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,297,000 | $430,182,160 | |
| 8 | CYTK |
Cytokinetics Inc
|
4,999,999 | $425,949,914 |
All Filings in MDGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $984,408,154 | 1,833,333 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $951,763,208 | 1,818,181 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,052,579,550 | 1,807,500 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $840,723,780 | 1,833,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $567,450,000 | 1,875,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $669,820,593 | 2,022,222 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $626,088,530 | 2,029,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $430,594,380 | 2,029,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $575,884,288 | 2,055,555 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $519,244,325 | 1,944,444 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $437,050,905 | 1,888,888 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $227,092,200 | 1,555,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $349,999,881 | 1,515,151 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $403,766,505 | 1,666,666 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $481,815,000 | 1,660,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $99,759,650 | 1,535,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $109,875,300 | 1,535,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $139,821,000 | 1,425,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $120,754,500 | 1,425,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $113,700,750 | 1,425,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $138,809,250 | 1,425,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $166,682,250 | 1,425,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $136,183,250 | 1,225,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $105,669,700 | 890,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $39,637,500 | 350,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $23,299,240 | 349,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||